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Sudden cardiac arrest (SCA) is a global health concern.
It is estimated that nearly half of all cardiovascular
deaths worldwide are due to SCA resulting in an esti-
mated 4 to 6 million cases each year [1,2]. Several coun-
tries have developed national out-of-hospital cardiac
arrest (OHCA) registries for surveillance and quality
improvement purposes including: Japan, Denmark,
Singapore, Korea, Sweden, Ireland and many others are
beginning to collect data. There are also collective
efforts in Asia (PAROS), Europe (EuReCa), and the Uni-
ted States (CARES) underway [3-5]. Collecting data is
an essential first step in determining the subsequent
steps needed to strengthen the chain-of-survival within
a community. It follows the business mantra that “it is
hard to manage something if you don’t measure it”.
Communities that don’t measure their OHCA outcomes
are not only unable to gauge their performance but also
lack a reference point to determine the impact of any
implemented quality improvement efforts. In 2010, the
American Heart Association recognized the importance
of data collection for OHCA and identified the essential
elements of a high quality resuscitation system that
includes: measurement, benchmarking and providing
feedback to influence change [6].
Registries
PAROS
The Pan-Asian Resuscitation Outcomes Study (PAROS)
network was established in 2009 as an international,
multicenter, prospective registry of OHCA events across
the Asia-Pacific. The goal of the network “is to provide
benchmarking against established registries and to gener-
ate best practice protocols for Asian emergency medical
services (EMS) systems, to impact community awareness
of pre-hospital emergency care, and ultimately to
improve OHCA survival” [3]. To date the registry
includes a population base of over 89 million with 9
countries being represented.
EuReCa
In 2008, the European Resuscitation Council set up a
working group with the goal of developing a common
European Registry of Cardiac Arrest (EuReCa) and to be
considered for use as a central tool for quality manage-
ment in resuscitation. A pilot was performed and it was
felt that it might best benefit those countries and regions
that had not already set up registries of their own [4].
CARES
In 2004, the US Center for Disease Control and Preven-
tion developed the Cardiac Arrest Registry to Improve
Survival (CARES) program https://mycares.net with the
Department of Emergency Medicine at the Emory Univer-
sity School of Medicine. The registry evaluates OHCA of
non-traumatic etiology for patients that receive resuscita-
tive efforts, including CPR and/or defibrillation. Participat-
ing sites include data from three sources that allow for a
patient centric outcome to be measured by linking data
from: EMS providers, dispatch centers and hospitals. In
the US the majority of persons who experience an OHCA
do not receive bystander-assisted CPR or other time sensi-
tive interventions that have been proven to increase survi-
val rates (e.g. defibrillation).
CARES was developed as a low cost, high impact pub-
lic health surveillance system to help identify opportu-
nities for improvement in OHCA care. It was designed
from the onset to make the process of data collection as
simple and easy as possible. Because CARES data are
collected in a uniform manner, the system enables
benchmarking and continuous quality improvement in
communities of any size. Nearly half of OHCA events
are witnessed, so efforts to improve survival should con-
sider the timely and effective delivery of interventions
by bystanders and emergency providers [5].
Emory University School of Medicine, Rollins School of Public Health, Atlanta,
Georgia, USA
McNally Scandinavian Journal of Trauma, Resuscitation and Emergency
Medicine 2014, 22(Suppl 1):A3
http://www.sjtrem.com/content/22/S1/A3
© 2014 McNally; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Global data trends and effectiveness
A recent data published from the Danish registry sug-
gests an improvement in survival over time with a cor-
responding increase in both bystander CPR and
defibrillation use [7]. The All Japan Utstein Registry has
also previously shown an increased survival trend over
time and an analysis currently under review for CARES
data suggests the same as well [8]. These improved sur-
vival trends are most likely multifactorial in nature and
since they are based on observational data it is impossi-
ble to pinpoint with certainty what is responsible for
these trends. An improved survival trend over time is
important to acknowledge but equally important is
understanding the limitations of registry data.
Efficacy is the extent to which a treatment has the
ability to bring about its intended effect under ideal cir-
cumstances, such as in a randomized clinical trial.
Effectiveness is the extent to which a treatment
achieves its intended effect in the usual clinical setting.
Efficacy is not the same as effectiveness. A treatment is
effective if it works in real life in non-ideal circum-
stances. Effectiveness cannot be measured in controlled
trials, because the act of inclusion into a study is a dis-
tortion of usual practice. Just as a randomized control
trial can’t be used to answer an effectiveness question
an observational study can’t be used to answer an effi-
cacy question. It is important to understand that both
study designs are needed to help advance our under-
standing of OHCA as neither alone can answer both
treatment and performance questions. This dual
requirement is highlighted below.
“It is an irony that drugs are licensed for use almost
exclusively on the results of controlled trials, yet they are
withdrawn from use because of observational data that
would not be acceptable to licensing authorities” [9].
In an editorial on the limitations of clinical trials in
cardiac arrest, author Arthur Sanders acknowledged that
“there are fundamental tensions between the principles
of randomized trial design and the practice of resuscita-
tion that make the conduct of any clinical trial of out-of
hospital cardiac arrest challenging”. He added that “Ran-
domized, controlled trials may not be the best strategy
for making progress in the management of a public
health problem” and considered that an alternative strat-
egy would be to use a continuous-quality-improvement
model.” He further concluded that “there are inherent
limitations in even a well-designed, carefully executed
clinical trial in advancing resuscitation science. It is
therefore important that we reassess the role of clinical
trials and alternative strategies in improving the rate of
survival from cardiac arrest. The goal of resuscitation is
saving lives; research helps achieve this goal but is not
the goal itself” [10].
The future
OHCA registries will continue to play an important role
in the future at both the community and country level.
Benefits will include: determining clinical outcomes;
uniform benchmarking; identifying opportunities for
improvement and tracking the diffusion of new therapies;
and promoting accountability and answering effective-
ness research questions.
Additional supplemental data elements could also be
considered to enhance registries to: track AED locations in
communities in real time to help a dispatcher link a caller
with a nearby device; include CPR quality metrics in an
effort to improve clinical performance by focusing on com-
pliance with recommended guidelines; including telephone
CPR data and quality improvement tools to ensure dis-
patchers recognize OHCA over the phone while minimiz-
ing the time from call receipt to instructions being
provided and eventual first compression being performed.
More robust hospital data could also be considered where
resources allow to improve timely reperfusion and
hypothermia treatment for OHCA patients when indicated.
OHCA data should be used as a starting point for
improving a community based system of care by partici-
pating in a registry and quality improvement program but
saving a life should continue to be the goal not proving
how you did it.
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